Gerard Brophy, EVP, Biopharma Production at Avantor, Inc. (AVTR), sold 125,395 shares at $27.84 ($3.5M) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $3.5M AVTR by EVP, Biopharma Production. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.15 | 6,559 | $185K | 5.3% |
| 2 | $27.84 | 59,418 | $1.7M | 47.4% |
| 3 | $27.84 | 59,418 | $1.7M | 47.4% |
| Total | $27.86 avg | 125,395 | $3.5M | 100% |
| Filing → |
| AVTR | SELL | 2023-02-02 | $568K | — | Filing → |
| AVTR | SELL | 2022-05-23 | $1.2M | — | Filing → |
| AVTR | SELL | 2022-03-02 | $140K | — | Filing → |